Drugs duo announce dupilumab in atopic dermatitis results

Sanofi and Regeneron Pharmaceuticals, Inc. have announced positive results from a phase IIb dose-ranging study of dupilumab in adult patients with moderate-to-severe atopic dermatitis.

Source: Pharmacy Europe - July 10, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Dermatology atopic dermatitis dupilumab Latest News new england journal of medicine regeneron sanofi Source Type: news